Current stock page

Financial Data

SYK Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Sep 4, 2026

SYK

Financial Data
Stryker Corporation
Healthcare· Medical - Devices
AIQ Score
NeutralAIQ Edge 3/10
Low Priority
Relative Laggard
Score data as of Sep 4, 2026
Last price
$303.13
-$4.86 (-1.58%)
Latest market quote
Momentum14
Value42
Quality66
Risk Resilience63
Sentiment58
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 7, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$6.59B$6.02B$7.17B$6.06B$6.02B$5.87B$6.44B$5.49B
Gross Profit$4.5B$3.81B$4.68B$3.85B$3.75B$3.68B$3.99B$3.39B
Operating Income
Net Income$1.28B$745M$849M$859M$884M$654M$546M$834M
EPS$3.32$1.95$2.21$2.25$2.32$1.71$1.43$2.19
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$1.26B$581M$2.14B$1.54B$1.11B$250M$1.93B$1.47B
Capital Expenditure-$202M-$166M-$268M-$187M-$183M-$123M-$266M-$170M
Free Cash Flow$1.06B$415M$1.88B$1.35B$928M$127M$1.67B$1.3B
Net Cash Provided By Operating Activities$1.26B$581M$2.14B$1.54B$1.11B$250M$1.93B$1.47B
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$47.93B$46.29B$47.84B$47.06B$46.33B$46.01B$42.97B$43.83B
Total Debt$14.94B$15.23B$14.86B$17.51B$17.13B$17.36B$14.12B$16.01B
Cash And Cash Equivalents
Total Liabilities$23.94B$23.31B$25.42B$25.27B$25.14B$25.08B$22.34B$23.68B
Total Stockholders Equity$23.99B$22.98B$22.42B$21.79B$21.19B$20.93B$20.63B$20.15B
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio23.7142.1339.5941.1442.7654.3162.8141.27
P/B ratio5.035.4866.497.146.796.656.83
P/S ratio18.3220.918.7523.3425.1124.2221.3125.06
Debt To Equity0.620.660.660.80.810.830.680.79
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio5.035.4866.497.146.796.656.83
P/S ratio18.3220.918.7523.3425.1124.2221.3125.06
Return On Equity5.32%3.24%3.79%3.94%4.17%3.12%2.65%4.14%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
32.62
multipleSep 4, 2026
Pb
5.07
multipleSep 4, 2026
Revenue Growth Yoy
9.45
percentSep 4, 2026
EPS Growth Yoy
70.26
percentSep 4, 2026
Gross Margin
65.17
percentSep 4, 2026
Operating Margin
22.03
percentSep 4, 2026
ROE
16.36
percentSep 4, 2026
ROIC
9.82
percentSep 4, 2026
Debt To Equity
0.62
ratioSep 4, 2026
FCF Yield
3.86
percentSep 4, 2026
Technical indicators
Close
303.13
priceSep 4, 2026
Volume
2,401,462
volumeSep 4, 2026
Rsi14
30.17
indexSep 4, 2026
MACD
-5.67
indexSep 4, 2026
MACD Signal
-2.18
indexSep 4, 2026
MACD Histogram
-3.49
indexSep 4, 2026
Adx14
12.71
indexSep 4, 2026
Sma50
328.91
priceSep 4, 2026
Sma200
338.45
priceSep 4, 2026
Atr14
9.85
priceSep 4, 2026
Historical Volatility
0.27
percentSep 4, 2026
Volume Ma20
2,235,766.2
volumeSep 4, 2026
Risk measures
Resilience Score
63
score_0_100Sep 4, 2026
Beta
0.77
ratioSep 4, 2026
Volatility Annual
28.12
percentSep 4, 2026
Max Drawdown
-28.34
percentSep 4, 2026
Sharpe Ratio
-0.94
ratioSep 4, 2026
Var95
-2.92
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

SYK Financial Data FAQ

What is Stryker Corporation's revenue?

Stryker Corporation's revenue is one of the core financial data points for SYK. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Stryker Corporation's revenue growing?

Revenue growth shows whether Stryker Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is SYK's EPS?

SYK's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Stryker Corporation's net income?

Stryker Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Stryker Corporation generate?

Free cash flow shows how much cash Stryker Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Stryker Corporation have?

Cash and debt help frame SYK's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.